IMG-92. An evidence-based framework for postoperative surveillance of meningioma

Abstract Meningiomas frequently recur after surgery. Existing guidelines for postoperative surveillance are based on customary practices or limited data. This may result in excessive or inadequate surveillance. We compared 8 studies involving 1,519 resected meningiomas with postoperative follow up ranging from 7 to 23 years. Meningiomas were stratified using the World Health Organization and Simpson grading systems, and progression free survival data were compared. Recurrence patterns were validated using two additional studies involving 2,463 meningiomas. Incompletely resected meningiomas of all grades displayed recurrences throughout the observation period. The 5-year and 10-year cumulative incidence of recurrence for completely resected Grade 1 meningiomas were 10% and 20%, with no recurrences beyond 11 years. For completely resected Grade 2 meningiomas, the 5-year and 10-year cumulative incidence of recurrence were 24% and 50%, with ongoing recurrences throughout the observation period. Elevated recurrence rates for Grade 1/2 meningiomas persisted beyond 5 years. For completely resected Grade 3 meningiomas, the 5-year cumulative incidence of recurrence was 63%, and all recurred before 10 years. Postoperative MRI at 48 hours to determine extent of resection and at 4 months to detect rapid regrowth are recommended. For completely resected Grade 1 meningiomas, annual MRI followed by discontinuation of surveillance if there is no recurrence after 11 years is reasonable. For completely resected Grade 2 meningiomas, annual MRI indefinitely is recommended. For Grade 3 meningiomas, MRI every 3-4 months for 2 years, followed by every 6 months indefinitely, is recommended. Incompletely resected meningiomas should be followed indefinitely.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-01
DOI
https://doi.org/10.1093/neuonc/noaf201.1171
Primary Topic
Meningioma and schwannoma management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IMG-92. An evidence-based framework for postoperative surveillance of meningioma

Connie Hou, Hanya M. Qureshi, M. Marasco, Rachael W. Sirianni et al.
Neuro-Oncology
Meningioma and schwannoma management
article

IMG-92. An evidence-based framework for postoperative surveillance of meningioma

Connie Hou, Hanya M. Qureshi, M. Marasco, Rachael W. Sirianni, Bethany C. Berry, Brittany Owusu‐Adjei, Rrita Daci, Umika Paul, William A. Lambert, Constance J. Mietus, Jeewoo Chelsea Lim, Mark D. Johnson
article en

Abstract

Abstract Meningiomas frequently recur after surgery. Existing guidelines for postoperative surveillance are based on customary practices or limited data. This may result in excessive or inadequate surveillance. We compared 8 studies involving 1,519 resected meningiomas with postoperative follow up ranging from 7 to 23 years. Meningiomas were stratified using the World Health Organization and Simpson grading systems, and progression free survival data were compared. Recurrence patterns were validated using two additional studies involving 2,463 meningiomas. Incompletely resected meningiomas of all grades displayed recurrences throughout the observation period. The 5-year and 10-year cumulative incidence of recurrence for completely resected Grade 1 meningiomas were 10% and 20%, with no recurrences beyond 11 years. For completely resected Grade 2 meningiomas, the 5-year and 10-year cumulative incidence of recurrence were 24% and 50%, with ongoing recurrences throughout the observation period. Elevated recurrence rates for Grade 1/2 meningiomas persisted beyond 5 years. For completely resected Grade 3 meningiomas, the 5-year cumulative incidence of recurrence was 63%, and all recurred before 10 years. Postoperative MRI at 48 hours to determine extent of resection and at 4 months to detect rapid regrowth are recommended. For completely resected Grade 1 meningiomas, annual MRI followed by discontinuation of surveillance if there is no recurrence after 11 years is reasonable. For completely resected Grade 2 meningiomas, annual MRI indefinitely is recommended. For Grade 3 meningiomas, MRI every 3-4 months for 2 years, followed by every 6 months indefinitely, is recommended. Incompletely resected meningiomas should be followed indefinitely.

Neuro-OncologyVol. 27(Supplement_5)
UMass Memorial Health Care (US), University of Massachusetts Chan Medical School (US), UMass Memorial Medical Center (US)
Openalex Percentile: Top 55%
Meningioma and schwannoma management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.